Δ9-Tetrahydrocannabinol discriminative stimulus effects of AM2201 and related aminoalkylindole analogs in rats

Behavioural Pharmacology

Volumn 27, Issue 2-3, 2016, Pages 211-214

  Järbe, Torbjörn U C ^a   Gifford, Roger S ^a   Zvonok, Alexander ^a   Makriyannis, Alexandros ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

'Spice K2'; AM2201; Analogs; Drug discrimination; Rat; Synthetic cannabinoids

Indexed keywords

1 (5 FLUOROPENTYL) 3 (1 NAPHTHOYL)INDOLE; AMINOALKYLINDOLE DERIVATIVE; DRONABINOL; INDOLE DERIVATIVE; RIMONABANT; UNCLASSIFIED DRUG; 1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG HALF LIFE; DRUG POTENCY; IN VIVO STUDY; MALE; NONHUMAN; RAT; ANIMAL; DISCRIMINATION LEARNING; DOSE RESPONSE; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; SPRAGUE DAWLEY RAT;

ANIMALS; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRONABINOL; INDOLES; MALE; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84962563809     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0000000000000196     Document Type: Article

References (18)

1. Banister SD, Stuart J, Kevin RC, Edington A, Longworth M, Wilkinson SM, et al. (2015). Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chem Neurosci 6:1445-1458.
2. Donohue K, Steiner R (2012). JWH-018 and JWH-022 as combustion products of AM2201. Microgram J 9:52-56.
3. Extance K, Goudie AJ (1981). Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology (Berl) 73:363-371.
4. Gatch MB, Forster MJ (2014). Delta9-tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice. Behav Pharmacol 25:750-757.
5. Järbe TUC (2011). Perceptual drug discriminative aspects of the endocannabinoid signaling system in animals and man. In: Glennon RA, Young R, editors. Drug discrimination: applications to medicinal chemistry and drug studies. Hoboken, NJ: John Wiley & Sons. pp. 241-285.
6. Järbe TUC, Lamb RJ, Lin S, Makriyannis A (2001). (R)-methanandamide and delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide. Psychopharmacology (Berl) 156:369-380.
7. Järbe TUC, Li C, Vadivel SK, Makriyannis A (2010). Discriminative stimulus functions of methanandamide and Δ9-THC in rats: Tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol. Psychopharmacology (Berl) 208:87-98.
8. Järbe TUC, Deng H, Vadivel SK, Makriyannis A (2011). Cannabinergic aminoalkylindoles, including AM678 =JWH018 found in 'Spice', examined using drug (Δ9-THC) discrimination for rats. Behav Pharmacol 22:498-507.
9. Makriyannis A, Deng H (2001). Cannabimimetic indole derivatives. World Patent "028557". WO2001/028557.
10. Monte AA, Bronstein AC, Cao DJ, Heard KJ, Hoppe JA, Hoyte CO, et al. (2014). An outbreak of exposure to a novel synthetic cannabinoid. N Engl J Med 370:389-390.
11. Rodgman CJ, Verrico CD, Worthy RB, Lewis EE (2014). Inpatient detoxification from a synthetic cannabinoid and control of postdetoxification cravings with naltrexone. Prim Care Companion CNS Disord 16.
12. Rodriguez JS, McMahon LR (2014). JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects. Eur J Pharmacol 740:151-159.
13. Sharma R, Nikas SP, Paronis CA, Wood JT, Halikhedkar A, Guo JJ, et al. (2013). Controlled-deactivation cannabinergic ligands. J Med Chem 56: 10142-10157.
14. Simões SS, Silva I, Ajenjo AC, Dias MJ (2014). Validation and application of an UPLC-MS/MS method for the quantification of synthetic cannabinoids in urine samples and analysis of seized materials from the Portuguese market. Forensic Sci Int 243:117-125.
15. Thakur GA, Nikas SP, Li C, Makriyannis A (2005). Structural requirements for cannabinoid receptor probes. Handb Exp Pharmacol 168:209-246.
16. Vigolo A, Ossato A, Trapella C, Vincenzi F, Rimondo C, Seri C, et al. (2015). Novel halogenated derivates of JWH-018: behavioral and binding studies in mice. Neuropharmacology 95:68-82.
17. Wiley JL, Compton DR, Dai D, Lainton JA, Phillips M, Huffman JW, Martin BR (1998). Structure-activity relationships of indole-and pyrrole-derived cannabinoids. J Pharmacol Exp Ther 285:995-1004.
18. Wohlfarth A, Scheidweiler KB, Castaneto M, Gandhi AS, Desrosiers NA, Klette KL, et al. (2015). Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens. Clin Chem Lab Med 53:423-434.